Dulcolax and Cayston drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Dulcolax (bisacodyl) and Cayston (aztreonam). Common drug interactions include infective pulmonary exacerbation of cystic fibrosis among females and ventricular pre-excitation among males.
The phase IV clinical study analyzes what interactions people have when they take Dulcolax and Cayston. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.
What is Dulcolax?
Dulcolax has active ingredients of bisacodyl. It is often used in constipation. eHealthMe is studying from 12,897 Dulcolax users. Check the latest studies of Dulcolax.
What is Cayston?
Cayston has active ingredients of aztreonam. It is often used in cystic fibrosis. eHealthMe is studying from 5,310 Cayston users. Check the latest studies of Cayston.
20 people who take Dulcolax and Cayston together, and have interactions are studied.

What are the common drug interactions of Dulcolax and Cayston, by gender? *:
female:
- Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
- Distal intestinal obstruction syndrome (blockage of the intestines by thickened stool and occurs in individuals with cystic fibrosis)
- Suicidal ideation
- Anxiety
- Bacterial infection
- Blood albumin decreased
- Blood calcium decreased
- Cough
- Decreased activity
- Decreased appetite
male:
- Ventricular pre-excitation
- Blood alkaline phosphatase increased
- Nausea (feeling of having an urge to vomit)
- Productive cough
- Pulmonary congestion (congestion in the lungs)
- Rhinorrhoea (watery mucus discharge from the nose)
- Sputum increased
- Vitamin d deficiency
- White blood cell count increased
- Chest discomfort
What are the common drug interactions of Dulcolax and Cayston, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
- Suicidal ideation
- Anxiety
- Depression
- Hypnopompic hallucination
- Hypoaesthesia (reduced sense of touch or sensation)
- Immune tolerance induction
- Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
- Influenza
- Nephrolithiasis (calculi in the kidneys)
- Panic attack
20-29:
- Blood alkaline phosphatase increased
- Chest discomfort
- Dyspnoea (difficult or laboured respiration)
- Forced expiratory volume decreased (decreased lung expired air volume)
- Glucose tolerance impaired (blood glucose is raised beyond normal levels, but not high enough to warrant a diabetes diagnosis)
- Haemoglobin decreased
- Heart rate increased
- Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
- Influenza
- Nausea (feeling of having an urge to vomit)
30-39:
n/a
40-49:
- Bacterial infection
- Glycosylated haemoglobin increased
- Headache (pain in head)
- Infective pulmonary exacerbation of cystic fibrosis (severe infective lung disease with production of abnormally thick mucus)
- Lymphocyte count decreased
- Nasal congestion (blockage of the nasal passages usually due to membranes lining the nose becoming swollen from inflamed blood vessels)
- Neutrophil count increased (excess than normal number of neutrophil a type of blood cell)
- Protein total decreased
- Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
- Sinusitis (inflammation of sinus)
50-59:
n/a
60+:
- Ventricular pre-excitation
What are the existing conditions these people have? *
- Pain: 8 people, 40.00%
- Pseudomonas Infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa): 7 people, 35.00%
- Infective Pulmonary Exacerbation Of Cystic Fibrosis (severe infective lung disease with production of abnormally thick mucus): 6 people, 30.00%
- Stress And Anxiety: 6 people, 30.00%
- Indigestion: 6 people, 30.00%
- Hypokalemia (low potassium): 6 people, 30.00%
- Depression: 4 people, 20.00%
- Headache (pain in head): 4 people, 20.00%
- Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 4 people, 20.00%
- Hypomagnesaemia (electrolyte disturbance in which there is an abnormally low level of magnesium in the blood): 4 people, 20.00%
* Approximation only. Some reports may have incomplete information.
Do you take Dulcolax and Cayston?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Dulcolax and Cayston:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Dulcolax:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Cayston:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Dulcolax and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Cayston and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zHow the study uses the data?
The study uses data from the FDA. It is based on bisacodyl and aztreonam (the active ingredients of Dulcolax and Cayston, respectively), and Dulcolax and Cayston (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Belsomra and Bactroban - a second ago
- Could Clobetasol Propionate cause Seasonal Allergy? - 2 seconds ago
- Could Pomalidomide cause Influenza Like Illness? - 5 seconds ago
- Drug interactions of Lovastatin and Combipatch - 12 seconds ago
- Could Edoxaban cause Abdominal Pain Upper? - 13 seconds ago
- Could Vicodin Hp cause Insomnia? - 14 seconds ago
- Could Losartan Potassium cause Facial Palsy Aggravated? - 16 seconds ago
- Drug interactions of Metoprolol Tartrate and Micafungin - 16 seconds ago
- Depression and Encephalopathy - 16 seconds ago
- Drug interactions of Alavert and Pepcid - 16 seconds ago